| Liver cancer | |
|---|---|
| Other names | Hepatic cancer, primary hepatic malignancy, primary liver cancer |
 |
|
| CT scan of a liver with cholangiocarcinoma | |
| Specialty | Gastroenterology Hepatology Oncology |
| Symptoms | Lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, weakness[1] |
| Usual onset | 55 to 65 years old[2] |
| Causes | hepatitis B, hepatitis C, alcoholism, aflatoxin, non-alcoholic fatty liver disease, liver flukes[3][4] |
| Diagnostic method | Blood tests, medical imaging, tissue biopsy[1] |
| Prevention | Immunization against hepatitis B, treating those infected with hepatitis B or C,[3] decreasing exposure to aflatoxin, decreasing high levels of alcohol consumption |
| Treatment | Surgery, targeted therapy, radiation therapy[1] |
| Prognosis | Five-year survival rates ~18% (US);[2] 40% (Japan)[5] |
| Frequency | 618,700 (point in time in 2015)[6] |
| Deaths | 782,000 (2018)[7] |
| Liver cancer | |
|---|---|
| Other names | Hepatic cancer, primary hepatic malignancy, primary liver cancer |
|
|
| CT scan of a liver with cholangiocarcinoma | |
| Specialty | Gastroenterology Hepatology Oncology |
| Symptoms | Lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, weakness[1] |
| Usual onset | 55 to 65 years old[2] |
| Causes | hepatitis B, hepatitis C, alcoholism, aflatoxin, non-alcoholic fatty liver disease, liver flukes[3][4] |
| Diagnostic method | Blood tests, medical imaging, tissue biopsy[1] |
| Prevention | Immunization against hepatitis B, treating those infected with hepatitis B or C,[3] decreasing exposure to aflatoxin, decreasing high levels of alcohol consumption |
| Treatment | Surgery, targeted therapy, radiation therapy[1] |
| Prognosis | Five-year survival rates ~18% (US);[2] 40% (Japan)[5] |
| Frequency | 618,700 (point in time in 2015)[6] |
| Deaths | 782,000 (2018)[7] |
